RxDoctor Payments Data

Jennifer Hartley

Acute Care · Seattle, WANPI 1609126606

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $82,006 of the $121,328 with a category attached, or 67.6%. AbbVie accounts for 99.7% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $99,420, more than ten times the $1,007 reported in 2021. Among acute care clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$121,328in general payments, 2019–2025

Across 421 payments — averaging $288.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$121K
  • Galderma Laboratories, L.p.$205
  • Astellas Pharma US Inc$146

What the payments were for

  • Consulting fees$10,2238%
  • Speaking & faculty fees$82,00668%
  • Travel & lodging$17,74415%
  • Food & beverage$10,6619%
  • Education$6951%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)416$120,976
Galderma Laboratories, L.p.2$205
Astellas Pharma US Inc3$146

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$121,328 in reported general payments places this provider in the 95th percentile of 135 acute care providers in Washington.

See all acute care providers in Washington

Other acute care in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →